Histone Deacetylase Inhibitors Promote Latent Adenovirus Reactivation from Tonsillectomy Specimens

Lingling Wang1,2, Mengyu Zhang1,2, Jingjing Li1,2

  • 1State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, Nanjing, Jiangsu, China.

Journal of Virology
|April 10, 2020
PubMed

Insights

Adenovirus (HAdV) DNA is common in tonsils, often latent. Histone deacetylase inhibitors can reactivate HAdV, explaining recurrent infections in children and immunocompromised individuals.

Area of Science:

  • Virology
  • Epigenetics
  • Immunology

Background:

  • Adenovirus (HAdV) infections are prevalent in children and immunocompromised individuals.
  • Recurrent HAdV infections, particularly in young children, can necessitate hospitalization.
  • HAdV is known to establish persistent or latent infections.

Purpose of the Study:

  • To investigate the presence of HAdV in tonsillectomy samples.
  • To explore the role of epigenetic factors in HAdV reactivation.
  • To identify compounds that can reactivate latent HAdV.

Main Methods:

  • Detection of HAdV DNA in tonsillectomy specimens.
  • Incubation of isolated lymphocytes to assess for infectious HAdV production.
  • Treatment of lymphocytes with an epigenetic compound library, followed by PCR and secondary infection assays to measure viral reactivation.

Main Results:

  • HAdV DNA was detected in 86.7% of tonsillectomy samples, with latent virus identified in lymphocytes.
  • Histone deacetylase (HDAC) inhibitors were found to reactivate latent HAdV.
  • Reactivation involved increased histone-3 acetylation at viral early gene promoters.

Conclusions:

  • Palatine tonsils serve as a reservoir for latent HAdV.
  • Histone acetylation plays a critical role in HAdV reactivation.
  • This mechanism links latent HAdV to recurrent infections.